Alpha-1 Resources
Resources on the Internet
The following websites contain helpful resources to support Alphas and their families:
- The Alpha-1 Association provides
information and resources to individuals affected with Alpha-1, facilitates a grassroots
network advocate for individuals with Alpha-1, and supports the goals of research
dedicated to curing Alpha-1 through collaboration with the Alpha-1 Foundation and
encouraging the participation of Alphas in research programs.
- The Alpha-1 Foundation
provides leadership and resources to increase research, improve health, achieve
worldwide detection, and find a cure for Alpha-1. This site contains an excellent
explanation of Alpha-1, provides health tips, and offers a free Alpha-1 testing
kit.
- The Alpha-1 Advocacy Alliance
was formed to improve the health and well being of Alpha-1 patients, educate healthcare
professionals about Alpha-1, and advance public policy for the Alpha-1 community.
This site connects patients to online discussion groups, medicine-related resources,
and other informational networks that advocate for individuals affected by Alpha-1.
- The COPD Foundation was
established to accelerate the development of more effective and affordable treatments
for COPD, expand services for COPD patients, and improve patients' lives through
research and education. This site provides programs, information lines, and research-related
resources for patients as well as treatment guidelines for medical professionals.
- The Pulmonary Education and
Research Foundation seeks to provide help for patients with chronic respiratory
disease through education and research, focusing on practical projects that benefit
patients with pulmonary disease. The site contains a number of links to scientific
articles, educational newsletters, and recent developments in research.
-
The Genetics Home Reference is the National Library of Medicine's website for
consumer information about genetic conditions and the genes or chromosomes related
to those conditions. The Alpha-1 section of the site addresses basic questions about
Alpha-1 and refers users to resources related to genetics, diagnosis, testing, and
treatment.
- The American Lung Association
is a leading organization that seeks to improve lung health and prevent lung disease
through education, advocacy, and research. This site contains basic information
about lung function and lung disease as well as more specific information about
diseases such as COPD.
-
The National Heart, Lung, and Blood Institute is a global organization that
provides leadership for research, training, and education programs to promote the
prevention and treatment of heart, lung, and blood diseases. This site includes
specific information about Alpha-1 including: causes, risks, symptoms, diagnosis,
treatments, and steps you can take to prevent or delay lung diseases related to
Alpha-1.
Important Safety Information
Alpha1-Proteinase Inhibitor (Human), Zemaira® is indicated for chronic augmentation and maintenance therapy for adults with alpha1-proteinase inhibitor (A1-PI) deficiency and emphysema. Clinical data demonstrating the long-term effects of chronic augmentation therapy with Zemaira are not available.
Zemaira may not be appropriate for the following adult individuals as they may experience severe reactions, including anaphylaxis: individuals with a known hypersensitivity and/or history of anaphylaxis or severe systemic reaction to A1-PI products or their components, and individuals with selective IgA deficiencies who have known antibodies against IgA.
In clinical studies, the following treatment-related adverse reactions were reported in 1% of subjects: asthenia (fatigue), injection-site pain, dizziness, headache, paresthesia (tingling), and pruritus (itching).
Zemaira is derived from human plasma. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.
Please see full prescribing information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.